{"id":54723,"date":"2023-03-10T14:05:22","date_gmt":"2023-03-10T13:05:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/"},"modified":"2023-03-10T14:05:22","modified_gmt":"2023-03-10T13:05:22","slug":"agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/","title":{"rendered":"Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu"},"content":{"rendered":"
\n

\nAn end-to-end digital pathology solution now available\n<\/p>\n

<\/a><\/p>\n

SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc.<\/a> (NYSE: A) today announced it has partnered with Hamamatsu Photonics K.K.<\/a>, a leading provider of whole slide imaging systems, to incorporate their NanoZoomer range including the S360MD Slide scanner system<\/a> into the Agilent end-to-end digital pathology solution. With the addition of the NanoZoomer Slide scanner systems, which converts glass slides into high-resolution digital data by high-speed scanning, Agilent completes its offering of an open and agnostic digital pathology workflow designed to accelerate breakthroughs in precision medicine.\n<\/p>\n

\nToday’s pathology labs face increasing pressure to manage greater patient and test loads with fewer pathologists, compounded by the growing trend toward remote work situations. To meet this challenge, many pathology laboratories are seeking new ways to improve workflow efficiency and facilitate remote analysis. These circumstances have highlighted the need for a digital pathology solution to increase laboratory efficiency, clinical utility, and test quality.\n<\/p>\n

\nBy incorporating Hamamatsu\u2019s slide scanning capability into its digital pathology solution, Agilent takes a significant step forward in its quest to support pathologists with an advanced platform that can reduce time-to-diagnostic and help improve patient outcomes. This scalable digital pathology workflow features scanners, an image management system, and digital pathology applications that are compatible with Agilent pathology solutions as well as other technology and laboratory information systems (LIS), allowing forward-thinking labs to benefit from flexible, future-proof technology that positions them for growth as requirements evolve.\n<\/p>\n

\n\u201cIncreasing cancer cases and tests have driven pathology labs towards the implementation of digital pathology,\u201d said Lou Welebob, vice president and general manager of Agilent\u2019s Pathology division, Diagnostics and Genomics Group. \u201cThis distribution agreement strengthens Agilent\u2019s open and agnostic end-to-end digital pathology offering and demonstrates our commitment to providing superior digital pathology solutions for our customers.\u201d\n<\/p>\n

\n\u201cTime is critical for patients and clinicians when awaiting a diagnosis. At Hamamatsu, our NanoZoomer Slide scanner digital pathology product line will help revolutionize the diagnostic process, enabling fast turnaround times, more efficient workflows, and more collaboration among pathologists worldwide. We are committed to facilitating the adoption of this transformative technology to help pathologists improve patient care and patient outcomes for every patient and, ultimately, anywhere in the world,\u201d said Laura Pagano, vice president of Sales at Hamamatsu Corporation.\n<\/p>\n

\nHamamatsu Photonics K.K. is a leading provider of whole slide imaging systems and related technology such as optical sensors, light sources, and complex instrument systems that use them. The FDA has recently granted 510(k) clearance to market their NanoZoomer S360MD slide scanner system for primary diagnostic use in the US market.\n<\/p>\n

\nAbout Agilent Technologies<\/b>\n<\/p>\n

\nAgilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent\u2019s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers’ most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. Information about Agilent is available at www.agilent.com<\/a>. To receive the latest Agilent news, please subscribe to the Agilent Newsroom<\/a>. Follow Agilent on LinkedIn<\/a> and Facebook<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nNaomi Goumillout
\n
Agilent Technologies
\n
+1.781.266.2819
\n
naomi.goumillout@agilent.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

An end-to-end digital pathology solution now available SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced it has partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, to incorporate their NanoZoomer range including the S360MD Slide scanner system into the Agilent end-to-end digital pathology solution. With the addition of the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54723","6":"format-standard","7":"category-industry"},"yoast_head":"\nAgilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"An end-to-end digital pathology solution now available SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced it has partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, to incorporate their NanoZoomer range including the S360MD Slide scanner system into the Agilent end-to-end digital pathology solution. With the addition of the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-10T13:05:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230310005049\/en\/738858\/21\/Logo-Agilent.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu\",\"datePublished\":\"2023-03-10T13:05:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\\\/\"},\"wordCount\":545,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230310005049\\\/en\\\/738858\\\/21\\\/Logo-Agilent.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\\\/\",\"name\":\"Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230310005049\\\/en\\\/738858\\\/21\\\/Logo-Agilent.jpg\",\"datePublished\":\"2023-03-10T13:05:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230310005049\\\/en\\\/738858\\\/21\\\/Logo-Agilent.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230310005049\\\/en\\\/738858\\\/21\\\/Logo-Agilent.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/","og_locale":"en_US","og_type":"article","og_title":"Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu - Pharma Trend","og_description":"An end-to-end digital pathology solution now available SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced it has partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, to incorporate their NanoZoomer range including the S360MD Slide scanner system into the Agilent end-to-end digital pathology solution. With the addition of the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-10T13:05:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230310005049\/en\/738858\/21\/Logo-Agilent.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu","datePublished":"2023-03-10T13:05:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/"},"wordCount":545,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230310005049\/en\/738858\/21\/Logo-Agilent.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/","url":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/","name":"Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230310005049\/en\/738858\/21\/Logo-Agilent.jpg","datePublished":"2023-03-10T13:05:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230310005049\/en\/738858\/21\/Logo-Agilent.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230310005049\/en\/738858\/21\/Logo-Agilent.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/agilent-announces-digital-pathology-scanner-distribution-agreement-with-hamamatsu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54723"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54723\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}